Fecula Biotech Co., Ltd.
Update：2026/09/15
Industries
Main Industry
Health Care
Main Product/Service
1. Development of novel drugs for gut microbiota-based cancer adjuvant therapy
2. Development of probiotic-related health foods
3. Application of utilizable agricultural resources in health foods
(The content above was translated by AI.)
2. Development of probiotic-related health foods
3. Application of utilizable agricultural resources in health foods
(The content above was translated by AI.)
Founded Year
2019
Unified Business No.
42932624
Status
Active
Number of Employees
7
Total Paid-in
Capital
45,035,695 (NT$)
Location of Company
Taiwan
, Tainan City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
We focuses on the development and reuse of agricultural and fishery waste, integrating the concepts of sustainability and circular economy. By leveraging biotechnology, we achieve a synergistic effect where 1+1 > 2.
In the context of surplus banana production, We utilizes biotechnology to develop resistant starch from bananas into a dual-layer encapsulation technology for probiotics. This innovation enhances the viability of beneficial bacteria and allows them to survive longer in the digestive tract.
In the context of surplus banana production, we utilize biotechnology to develop resistant starch from bananas into a dual-layer encapsulation technology for probiotics. This innovation enhances the viability of beneficial bacteria and allows them to survive longer in the digestive tract. efficient colonization. Additionally, resistant starch promotes the growth of beneficial bacteria in the digestive system, offering greater health advantages!
In the context of surplus banana production, We utilizes biotechnology to develop resistant starch from bananas into a dual-layer encapsulation technology for probiotics. This innovation enhances the viability of beneficial bacteria and allows them to survive longer in the digestive tract.
In the context of surplus banana production, we utilize biotechnology to develop resistant starch from bananas into a dual-layer encapsulation technology for probiotics. This innovation enhances the viability of beneficial bacteria and allows them to survive longer in the digestive tract. efficient colonization. Additionally, resistant starch promotes the growth of beneficial bacteria in the digestive system, offering greater health advantages!
Corporate Video
